Biotech ETFs Lead Tradable Funds
The biotech-focused exchange-traded
funds led their peers Monday after a favorable write-up in Barron’s on two
big-cap biotechs, Biogen and Genentech, boosted the industry group.
The Nasdaq Biotechnology iShares
(
IBB |
Quote |
Chart |
News |
PowerRating)
gained 3.3%, the day’s biggest gain among the exchange-traded
funds. The Biotech HOLDR
(
BBH |
Quote |
Chart |
News |
PowerRating) added 2.7%.
Energy had a decent day with the Oil
Services HOLDR
(
OIH |
Quote |
Chart |
News |
PowerRating) picking up 2.2%, the Dow Jones Energy iShares
(
IYE |
Quote |
Chart |
News |
PowerRating)
1.7%, the Energy SPDR
(
XLE |
Quote |
Chart |
News |
PowerRating) 1.4%.
On the downsidde, the Internet
Infrastructure HOLDR
(
IIH |
Quote |
Chart |
News |
PowerRating) lost 1.6%, the Semiconductor HOLDR
(
SMH |
Quote |
Chart |
News |
PowerRating)
1.3%, the Broadband HOLDR
(
BDH |
Quote |
Chart |
News |
PowerRating) 0.9%.